Clinical Trial Update: Galantamine Treatment for Nonfluent Aphasia in Stroke Patients [NA]

View source ↗

Summary

Clinical trial evaluating galantamine for nonfluent aphasia in stroke patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphasia
• Stroke

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Aphasia, Stroke | NA | Status: COMPLETED